• 1
    Goldstein IM. Complement-biologically active products. In: GallinJI, GoldsteinIM, SnydermanR, eds. Inflammation: Basic Principles and Clinical Correlates, 2nd edn. New York: Raven Press, 1992: 6380.
  • 2
    Gerard C, Gerard NP. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol 1994; 12 : 775808.
  • 3
    Boulay F, Mery L, Tardif M, Brouchon L, Vignais P. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 1991; 30 : 29939.
  • 4
    Zwirner J, Fayyazi A, Gotze O. Expression of the anaphylatoxin C5a receptor in non-myeloid cells. Mol Immunol 1999; 36 : 87784.
  • 5
    Werfel T, Oppermann M, Schulze M, Krieger G, Weber M, Gotze O. Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes. Blood 1992; 79 : 15260.
  • 6
    Frank MM, Fries LF. The role of complement in inflammation and phagocytosis. Immunol Today 1991; 12 : 3226.
  • 7
    Werfel T, Sonntag G, Weber MH, Gotze O. Rapid increases in the membrane expression of neutral endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fc gamma-RIII (CD16) upon stimulation of human peripheral leukocytes with human C5a. J Immunol 1991; 147 : 390914.
  • 8
    Elsner J, Dichmann S, Kapp A. Activation of the respiratory burst in human eosinophils by chemotaxins requires intracellular calcium fluxes. J Invest Dermatol 1995; 105 : 2316.
  • 9
    Fayyazi A, Sandau R, Duong LQ, Gotze O, Radzun HJ, Schweyer S, Soruri A, Zwirner J. C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells. Am J Pathol 1999; 154 : 495501.
  • 10
    Harris JA, Hyde DM, Wang QJ, Stovall MY, Giri SN. Repeated episodes of C5a-induced neutrophil influx do not result in pulmonary fibrosis. Inflammation 1991; 15 : 23350.
  • 11
    Ember JA, Sanderson SD, Hugli TE, Morgan EL. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol 1994; 144 : 393403.
  • 12
    Montz H, Koch KC, Zierz R, Gotze O. The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1. Immunology 1991; 74 : 3739.
  • 13
    Morin M, Schindler R, Wakabayashi G, Daumy G, Dinarello CA, Gelfand JA. Picogram concentrations of endotoxin stimulate synthesis of IL-1 beta and TNF alpha by human peripheral blood mononuclear cells exposed to recombinant human C5a. Eur Cytokine Netw 1991; 2 : 2730.
  • 14
    Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990; 37 : 8593.
  • 15
    Wittmann M, Zwirner J, Larsson VA, Kirchhoff K, Begemann G, Kapp A, Gotze O, Werfel T. C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. J Immunol 1999; 162 : 67639.
  • 16
    Tsuji RF, Geba GP, Wang Y, Kawamoto K, Matis LA, Askenase PW. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon gamma: a possible initiating role of B cells. J Exp Med 1997; 186 : 101526.
  • 17
    Tsuji RF, Kawikova I, Ramabhadran R, Akahira-Azuma M, Taub D, Hugli TE, Gerard C, Askenase PW. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol 2000; 165 : 158898.
  • 18
    Karp CL, Grupe A, Schadt E et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol 2000; 1 : 2216.
  • 19
    Banfield CC, Callard RE, Harper JI. The role of cutaneous dendritic cells in the immunopathogenesis of atopic dermatitis. Br J Dermatol 2001; 144 : 9406.
  • 20
    Till SJ, Jacobson MR, O'Brien F, Durham SR, KleinJan A, Fokkens WJ, Juliusson S, Lowhagen O. Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy. Allergy 2001; 56 : 12631.
  • 21
    Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000; 106 : 5519.
  • 22
    Bertorelli G, Bocchino V, Zhou X, Zanini A, Bernini MV, Di Damia RCV, Grima P, Olivieri D. Dendritic cell number is related to IL-4 expression in the airways of atopic asthmatic subjects. Allergy 2000; 55 : 44954.
  • 23
    Braun MC, Lahey E, Kelsall BL. Selective suppression of IL-12 production by chemoattractants. J Immunol 2000; 164 : 300917.
  • 24
    Kirchhoff K, Weinmann O, Zwirner J, Begemann G, Gotze O, Kapp A, Werfel T. Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin. Immunology 2001; 103 : 2107.
  • 25
    Morelli A, Larregina A, Chuluyan I, Kolkowski E, Fainboim L. Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells. Immunology 1996; 89 : 12634.
  • 26
    Yang D, Chen Q, Stoll S, Chen X, Howard OM, Oppenheim JJ. Differential regulation of responsiveness to fMLP and C5a upon dendritic cell maturation: correlation with receptor expression. J Immunol 2000; 165 : 2694702.
  • 27
    Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392 : 24552.
  • 28
    Gong JL, McCarthy KM, Telford J, Tamatani T, Miyasaka M, Schneeberger EE. Intraepithelial airway dendritic cells: a distinct subset of pulmonary dendritic cells obtained by microdissection. J Exp Med 1992; 175 : 797807.
  • 29
    Nestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets[published erratum appears in J Immunol 1994; 152(1): 376]. J Immunol 1993; 151 : 6535–45.
  • 30
    Gutzmer R, Langer K, Lisewski M, Mommert S, Rieckborn D, Kapp A, Werfel T. Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. J Allergy Clin Immunol 2002; 109 : 52431.
  • 31
    Oppermann M, Raedt U, Hebell T, Schmidt B, Zimmermann B, Gotze O. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain. J Immunol 1993; 151 : 378594.
  • 32
    Werfel T, Zwirner J, Oppermann M, Sieber A, Begemann G, Drommer W, Kapp A, Gotze O. CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin. J Immunol 1996; 157 : 172935.
  • 33
    Howard TH, Meyer WH. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils. J Cell Biol 1984; 98 : 126571.
  • 34
    Monsinjon T, Gasque P, Chan P, Ischenko A, Brady JJ, Fontaine MC. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J 2003; 17 : 100314.
  • 35
    Ebner S, Ratzinger G, Krosbacher B et al. Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4. J Immunol 2001; 166 : 63341.
  • 36
    Chang CC, Wright A, Punnonen J. Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation. J Immunol 2000; 165 : 358491.
  • 37
    Mrowietz U, Koch WA, Zhu K, Wiedow O, Bartels J, Christophers E, Schroder JM. Psoriasis scales contain C5a as the predominant chemotaxin for monocyte-derived dendritic cells. Exp Dermatol 2001; 10 : 23845.
  • 38
    Sozzani S, Sallusto F, Luini W et al. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol 1995; 155 : 32925.
  • 39
    Scandella E, Men Y, Gillessen S, Forster R, Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002; 100 : 135461.
  • 40
    Luft T, Jefford M, Luetjens P et al. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli. prostaglandin E (2) regulates the migratory capacity of specific DC subsets. Blood 2002; 100 : 136272.
  • 41
    Nestle FO, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest 1994; 94 : 2029.
  • 42
    Koga T, Duan H, Urabe K, Furue M. In situ localization of CD83-positive dendritic cells in psoriatic lesions. Dermatology 2002; 204 : 1003.
  • 43
    Reilly DM, Parslew R, Sharpe GR, Powell S, Green MR. Inflammatory mediators in normal, sensitive and diseased skin types. Acta Derm Venereol 2000; 80 : 1714.
  • 44
    D'Amico G, Frascaroli G, Bianchi G et al. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol 2000; 1 : 38791.
  • 45
    Bergh K, Iversen OJ, Lysvand H. Surprisingly high levels of anaphylatoxin C5a des Arg are extractable from psoriatic scales. Arch Dermatol Res 1993; 285 : 1314.
  • 46
    Takematsu H, Tagami H. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin. Arch Dermatol 1993; 129 : 7480.